Kraemer SA, Ramachandran A, Perron GG. Antibiotic pollution in the environment: from microbial ecology to public policy. Microorganisms. 2019;7(6):180.

CAS  PubMed  PubMed Central  Google Scholar 

Crone S, Vives-Flórez M, Kvich L, Saunders AM, Malone M, Nicolaisen MH, et al. The environmental occurrence of Pseudomonas aeruginosa. Apmis. 2020;128(3):220–31.

CAS  PubMed  Google Scholar 

Olga P, Apostolos V, Alexis G, George V, Athena M. Antibiotic resistance profiles of Pseudomonas aeruginosa isolated from various Greek aquatic environments. FEMS Microbiol Ecol. 2016;92(5):fiw042.

PubMed  Google Scholar 

Sharahi JY, Azimi T, Shariati A, Safari H, Tehrani MK, Hashemi A. Advanced strategies for combating bacterial biofilms. J Cell Physiol. 2019;234(9):14689–708.

CAS  PubMed  Google Scholar 

Mohsenzadeh A, Fazel A, Bavari S, Borji S, Pourasghar S, Azimi T, et al. Detecting of biofilm formation in the clinical isolates of Pseudomonas aeruginosa and Escherichia coli: an evaluation of different screening methods. J Curr Biomedical Rep. 2021;2(2):56–61.

Google Scholar 

Park S-C, Lee M-Y, Kim J-Y, Kim H, Jung M, Shin M-K, et al. Anti-biofilm effects of synthetic antimicrobial peptides against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus planktonic cells and biofilm. Molecules. 2019;24(24):4560.

CAS  PubMed  PubMed Central  Google Scholar 

Bagge N, Hentzer M, Andersen JB, Ciofu O, Givskov M, Høiby N. Dynamics and Spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2004;48(4):1168–74.

CAS  PubMed  PubMed Central  Google Scholar 

Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med. 2013;39:672–81.

PubMed  Google Scholar 

Okamoto K, Gotoh N, Nishino T. Pseudomonas aeruginosa reveals high intrinsic resistance to Penem antibiotics: Penem resistance mechanisms and their interplay. Antimicrob Agents Chemother. 2001;45(7):1964–71.

CAS  PubMed  PubMed Central  Google Scholar 

Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ. 2004;328(7441):668.

CAS  PubMed  PubMed Central  Google Scholar 

Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49(2):479–87.

CAS  PubMed  PubMed Central  Google Scholar 

Rello J, Allegri C, Rodriguez A, Vidaur L, Sirgo G, Gomez F, et al. Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology. 2006;105(4):709–14.

PubMed  Google Scholar 

Horcajada J, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect. 2013;19(10):962–8.

CAS  PubMed  Google Scholar 

Rehman A, Patrick WM, Lamont IL. Mechanisms of Ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol. 2019;68(1):1–10.

CAS  PubMed  Google Scholar 

Xu Y, Wang Y, Yan L, Liang R-M, Dai B-D, Tang R-J, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and Berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res. 2009;8(11):5296–304.

CAS  PubMed  Google Scholar 

Yu H-H, Kim K-J, Cha J-D, Kim H-K, Lee Y-E, Choi N-Y, et al. Antimicrobial activity of Berberine alone and in combination with ampicillin or Oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food. 2005;8(4):454–61.

CAS  PubMed  Google Scholar 

Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of Berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci. 2000;97(4):1433–7.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Zhang B, Xing K, Zhang X, Tian X, Dai W. Inhibitory effects of golden thread (Coptis chinensis) and Berberine on Microcystis aeruginosa. Water Sci Technol. 2010;61(3):763–9.

PubMed  Google Scholar 

Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis. 2000;30(2):243–54.

CAS  PubMed  Google Scholar 

Andriole VT. The quinolones: past, present, and future. Clin Infect Dis. 2005;41(Supplement2):S113–9.

CAS  PubMed  Google Scholar 

Kłodzińska SN, Priemel PA, Rades T, Mørck Nielsen H. Inhalable antimicrobials for treatment of bacterial biofilm-associated sinusitis in cystic fibrosis patients: challenges and drug delivery approaches. Int J Mol Sci. 2016;17(10):1688.

PubMed  PubMed Central  Google Scholar 

Paulsson M, Granrot A, Ahl J, Tham J, Resman F, Riesbeck K, et al. Antimicrobial combination treatment including Ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2017;36:1187–96.

CAS  PubMed  PubMed Central  Google Scholar 

Raz R, Miron D. Oral Ciprofloxacin for treatment of infection following nail puncture wounds of the foot. Clin Infect Dis. 1995;21(1):194–5.

CAS  PubMed  Google Scholar 

Mösges R, Nematian-Samani M, Eichel A. Treatment of acute otitis externa with Ciprofloxacin otic 0.2% antibiotic ear solution. Ther Clin Risk Manag. 2011:325–36.

Remmington T, Jahnke N, Harkensee C. Oral anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Reviews. 2013(10).

Pitt T, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax. 2003;58(9):794–6.

CAS  PubMed  PubMed Central  Google Scholar 

Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in brooklyn, NY. J Antimicrob Chemother. 2007;60(1):78–82.

CAS  PubMed  Google Scholar 

Rouhi S, Ramazanzadeh R, Nouri B. Genotyping, pandrug resistance, extensively drug-resistant, and multi drug-resistance detection of pseudomonas aeruginosa isolated from patients in the West of Iran. Crescent J Med Biol Sci. 2019;6(2).

Motoshima M, Yanagihara K, Fukushima K, Matsuda J, Sugahara K, Hirakata Y, et al. Rapid and accurate detection of Pseudomonas aeruginosa by real-time polymerase chain reaction with melting curve analysis targeting GyrB gene. Diagn Microbiol Infect Dis. 2007;58(1):53–8.

CAS  PubMed  Google Scholar 

Agaras BC, Valverde C. A novel oligonucleotide pair for genotyping members of the Pseudomonas genus by single-round PCR amplification of the GyrB gene. Methods Protocols. 2018;1(3):24.

CAS  PubMed Central  Google Scholar 

Heidari R, Farajzadeh Sheikh A, Hashemzadeh M, Farshadzadeh Z, Salmanzadeh S, Saki M. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in Southwestern Iran. Mol Biol Rep. 2022;49(5):3811–22.

CAS  PubMed  PubMed Central  Google Scholar 

Cockerill FR. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. (No Title). 2012.

Rancan F, Contardi M, Jurisch J, Blume-Peytavi U, Vogt A, Bayer IS, et al. Evaluation of drug delivery and efficacy of ciprofloxacin-loaded Povidone foils and nanofiber Mats in a wound-infection model based on ex vivo human skin. Pharmaceutics. 2019;11(10):527.

CAS  PubMed  PubMed Central  Google Scholar 

Davarzani F, Saidi N, Besharati S, Saderi H, Rasooli I, Owlia P. Evaluation of antibiotic resistance pattern, alginate and biofilm production in clinical isolates of Pseudomonas aeruginosa. Iran J Public Health. 2021;50(2):341.

PubMed  PubMed Central  Google Scholar 

Ajish C, Kumar SD, Kim EY, Yang S, Shin SY. A short novel antimicrobial peptide BP100-W with antimicrobial, antibiofilm and anti-inflammatory activities designed by replacement with Tryptophan. J Anal Sci Technol. 2022;13(1):46.

CAS  Google Scholar 

Ndezo Bisso B, Tokam Kuaté CR, Boulens N, Allémann E, Delie F, Dzoyem JP. Antibiofilm synergistic activity of streptomycin in combination with Thymol-Loaded Poly (Lactic‐co‐glycolic Acid) nanoparticles against Klebsiella pneumoniae isolates. Evidence‐Based Complement Altern Med. 2022;2022(1):1936165.

Google Scholar 

Dall G, Tsang SJ, Gwynne P, MacKenzie S, Simpson A, Breusch S, et al. Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms. J Antimicrob Chemother. 2018;73(7):1830–40.

CAS  PubMed  Google Scholar 

Thieme L, Hartung A, Tramm K, Klinger-Strobel M, Jandt KD, Makarewicz O, et al. MBEC versus MBIC: the lack of differentiation between biofilm reducing and inhibitory effects as a current problem in biofilm methodology. Biol Procedures Online. 2019;21:1–5.

CAS  Google Scholar 

Jayaraman P, Sakharkar MK, Lim CS, Tang TH, Sakharkar KR. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci. 2010;6(6):556.

CAS  PubMed